Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.14% Nasdaq Up0.86%

Allergan Inc. (AGN)

-NYSE

114.08 Apr 22, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Sep 29, 2012Jun 29, 2012Mar 30, 2012
Total Revenue 1,508,900   1,413,900   1,491,400   1,391,900  
Cost of Revenue189,200  188,800  201,700  195,800  
Gross Profit 1,319,700   1,225,100   1,289,700   1,196,100  
Operating Expenses
Research Development239,300  293,300  232,000  225,000  
Selling General and Administrative557,900  540,800  584,600  585,100  
Non Recurring23,300  3,800  900   -  
Others33,200  33,200  33,300  31,600  
Total Operating Expenses853,700  871,100  850,800   -  
Operating Income or Loss 466,000   354,000   438,900   354,400  
Income from Continuing Operations
Total Other Income/Expenses Net(1,900)(7,300)6,600  (13,800)
Earnings Before Interest And Taxes464,100  346,700  445,500  340,600  
Interest Expense14,800  15,900  17,100  15,800  
Income Before Tax449,300  330,800  428,400  324,800  
Income Tax Expense124,100  80,200  132,000  94,500  
Minority Interest(1,000)(1,200)(1,000)(500)
Net Income From Continuing Ops324,200  249,400  295,400  229,800  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 324,200   249,400   295,400   229,800  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 324,200   249,400   295,400   229,800  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.